G1 Therapeutics, Inc. (GTHX) earnings
Quarterly and annual GTHX reports and results, each read against the price at its own news timestamp. Back to the GTHX overview →
9 measured GTHX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q G1 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.07% | +0.14% | |
| G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights | Press release | +0.25% | +0.57% | |
| G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 | Press release | +0.27% | +4.78% | |
| Form 10-Q G1 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.65% | +6.99% | |
| G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights | Press release | +5.68% | +17.33% | |
| G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024 | Press release | +1.93% | +3.13% | |
| Form 10-K G1 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.50% | +3.75% | |
| Form 10-Q G1 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.03% | +23.48% | |
| G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights | Press release | +1.85% | -0.74% |
Keep exploring
More GTHX: analyst actions → · SEC filings → · GTHX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
| Alimera Sciences, Inc. (ALIM) | 142 | 0.00% | 42% |
| InflaRx N.V. (IFRX) | 142 | 0.00% | 48% |
| Oncocyte Corporation (OCX) | 141 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.